pentobarbital will decrease the level or impact of mavacamten by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated.pentobarbital will reduce the extent or outcome of cannabidiol by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Observe Carefully. Consider a rise in cannabidiol dosage (based upon medical